Overview

Proton Pump Inhibitor Treatment Stop

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine how many chronic users of antisecretory medication can stop after a test for a bacteria associated with peptic ulcer disease. This is evaluated in a discontinuation trial.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Odense University Hospital
Collaborators:
Apotekerfonden af 1991
AstraZeneca
Danish College of General Practitioners
Research Unit of General Practice, Odense
The Danish Medical Research Council
University of Southern Denmark
Treatments:
Esomeprazole
Proton Pump Inhibitors
Criteria
Inclusion Criteria:

- Use of antisecretory medication for more than 2 months during the last 6 months

Exclusion Criteria:

- Malignity or severe, competing medical or psychiatric disease

- Esophagitis (proven by endoscopy)

- Prior complication to peptic ulcer disease

- Alarm symptoms

- Pregnancy or lactation

- Allergy towards esomeprazole

- Planned hospitalisation during study period